Human mesenchymal stem cell grafts enhance normal and impaired wound healing by recruiting existing endogenous tissue stem/progenitor cells

Stem Cells Translational Medicine

Volumn 2, Issue 1, 2013, Pages 33-42

  Shin, Laura ^a   Peterson, Daniel A ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Adult human bone marrow; Cellular therapy; Diabetes; Mesenchymal stem cells; Progenitor cells; Stem cell; Tissue regeneration

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; CD34 ANTIGEN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; THY 1 ANTIGEN; VASCULOTROPIN; WNT3A PROTEIN; LEUKOCYTE ANTIGEN; SIGNAL PEPTIDE; TRANSCRIPTOME; WNT3A PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DIABETES MELLITUS; ENGRAFTMENT; FIBROBLAST; FLOW CYTOMETRY; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN CELL; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE REPAIR; WOUND; WOUND HEALING; ANIMAL; C57BL MOUSE; CELL CULTURE; GENETICS; INJURY; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; SKIN; SOFT TISSUE INJURY; STEM CELL;

ANIMALS; ANTIGENS, CD; CELLS, CULTURED; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MESENCHYMAL STEM CELL TRANSPLANTATION; MICE; MICE, INBRED C57BL; MICE, OBESE; SKIN; SOFT TISSUE INJURIES; STEM CELLS; TRANSCRIPTOME; WNT3A PROTEIN; WOUND HEALING;

MLCS; MLOWN;

EID: 84873422794     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2012-0041     Document Type: Article

References (38)

1. Sorrell JM, Caplan AI. Topical delivery of mesenchymal stem cells and their function in wounds. Stem Cell Res Ther 2010; 1:30.
2. Crisan M, Yap S, Casteilla L et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008; 3:301-313.
3. Chen FH, Tuan RS. Mesenchymal stem cells in arthritic diseases. Arthritis Res Ther 2008; 10:223.
4. Chen L, Tredget EE, Wu PY et al. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One 2008; 3:e1886.
5. Wu Y, Chen L, Scott PG et al. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. STEM CELLS 2007; 25:2648-2659.
6. Prockop DJ, Gregory CA, Spees JL. One strategy for cell and gene therapy: Harnessing the power of adult stem cells to repair tissues. Proc Natl Acad Sci USA 2003; 100(suppl 1): 11917-11923.
7. Karp JM, Leng Teo GS. Mesenchymal stem cell homing: The devil is in the details. Cell Stem Cell 2009; 4:206-216.
8. Hatzistergos KE, Quevedo H, Oskouei BN et al. Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res 2010; 107:913-922.
9. Javazon EH, Keswani SG, Badillo AT et al. Enhanced epithelial gap closure and increased angiogenesis in wounds of diabetic mice treated with adult murine bone marrow stromal progenitor cells. Wound Repair Regen 2007; 15:350-359.
10. Daley GQ, Scadden DT. Prospects for stem cell-based therapy. Cell 2008; 132:544-548.
11. Jackson WM, Nesti LJ, Tuan RS. Mesenchymal stem cell therapy for attenuation of scar formation during wound healing. Stem Cell Res Ther 2012; 3:20.
12. Tasso R, Augello A, Boccardo S et al. Recruitment of a host's osteoprogenitor cells using exogenous mesenchymal stem cells seeded on porous ceramic. Tissue Eng Part A 2009; 15: 2203-2212.
13. Le Blanc K, Frassoni F, Ball L et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study. Lancet 2008; 371:1579-1586.
14. Giordano A, Galderisi U, Marino IR. From the laboratory bench to the patient's bedside: An update on clinical trials with mesenchymal stem cells. J Cell Physiol 2007; 211:27-35.
15. Tolar J, Ishida-Yamamoto A, Riddle M et al. Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells. Blood 2009; 113:1167-1174.
16. Fiorina P, Pietramaggiori G, Scherer SS et al. The mobilization and effect of endogenous bone marrow progenitor cells in diabetic wound healing. Cell Transplant 2010; 19:1369-1381.
17. Shin L, Peterson DA. Impaired therapeutic capacity of autologous stem cells in a model of type 2 diabetes. STEM CELLS TRANSLATIONAL MEDICINE 2012; 1:125-135.
18. Badillo AT, Redden RA, Zhang L et al. Treatment of diabetic wounds with fetal murine mesenchymal stromal cells enhances wound closure. Cell Tissue Res 2007; 329:301-311.
19. Arthur A, Zannettino A, Gronthos S. The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair. J Cell Physiol 2009; 218:237-245.
20. Vega CJ, Peterson DA. Stem cell proliferative history in tissue revealed by temporal halogenated thymidine analog discrimination. Nat Methods 2005; 2:167-169.
21. Galiano RD, Michaels J, Dobryansky M et al. Quantitative and reproducible murine model of excisional wound healing. Wound Repair Regen 2004; 12:485-492.
22. Carlson MA, Thompson JS. Wound splinting modulates granulation tissue proliferation. Matrix Biol 2004; 23:243-250.
23. Thomas RM, Hotsenpiller G, Peterson D. Acute psychosocial stress reduces cell survival in adult hippocampal neurogenesis without altering proliferation. J Neurosci 2007; 27:2734-2743.
24. Prockop DJ, Kota DJ, Bazhanov N et al. Evolving paradigms for repair of tissues by adult stem/progenitor cells (MSCs). J Cell Mol Med 2010; 14:2190-2199.
25. Braga LM, Rosa K, Rodrigues B et al. Systemic delivery of adult stem cells improves cardiac function in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 2008; 35:113-119.
26. Ohnishi S, Ohgushi H, Kitamura S et al. Mesenchymal stem cells for the treatment of heart failure. Int J Hematol 2007; 86:17-21.
27. Lee RH, Pulin AA, Seo MJ et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 2009; 5:54-63.
28. Meirelles Lda S, Fontes AM, Covas DT et al. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev 2009; 20:419-427.
29. Bonfield TL, Caplan AI. Adult mesenchymal stem cells: An innovative therapeutic for lung diseases. Discov Med 2010; 9:337-345.
30. Augello A, Kurth TB, De Bari C. Mesenchymal stem cells: A perspective from in vitro cultures to in vivo migration and niches. Eur Cell Mater 2010; 20:121-133.
31. Mouiseddine M, Francois S, Semont A et al. Human mesenchymal stem cells home specifically to radiation-injured tissues in a nonobese diabetes/severe combined immunodeficiency mouse model. Br J Radiol 2007; 80(Spec no. 1):S49-S55.
32. Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells: Revisiting history, concepts, and assays. Cell Stem Cell 2008; 2:313-319.
33. Méndez-Ferrer S, Michurina TV, Ferraro F et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010; 466:829-834.
34. Shi Y, Hu G, Su J et al. Mesenchymal stem cells: A new strategy for immunosuppression and tissue repair. Cell Res 2010; 20:510-518.
35. Tang J, Wang J, Yang J et al. Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats. Eur J Cardiothorac Surg 2009; 36:644-650.
36. Mishima Y, Lotz M. Chemotaxis of human articular chondrocytes and mesenchymal stem cells. J Orthop Res 2008; 26:1407-1412.
37. Neth P, Ciccarella M, Egea V et al. Wnt signaling regulates the invasion capacity of human mesenchymal stem cells. STEM CELLS 2006; 24:1892-1903.
38. Shang YC, Wang SH, Xiong F et al. Wnt3a signaling promotes proliferation, myogenic differentiation, and migration of rat bone marrow mesenchymal stem cells. Acta Pharmacol Sin 2007; 28:1761-1774.